Liver transplantation for diethylnitrosamine-induced hepatocellular carcinoma in rats.
作者信息
Matsuzaki T, Murase N, Yagihashi A, Shinozuka H, Shimizu Y, Furuya T, Burrell N, Iwatsuki S, Starzl T E
机构信息
Department of Surgery, University Health Center of Pittsburgh, University of Pittsburgh, PA 15213.
出版信息
Transplant Proc. 1992 Apr;24(2):748-51.
Abstract
摘要
相似文献
1
Liver transplantation for diethylnitrosamine-induced hepatocellular carcinoma in rats.二乙基亚硝胺诱导的大鼠肝细胞癌的肝移植
Transplant Proc. 1992 Apr;24(2):748-51.
2
Role of immunosuppression in recurrence after liver transplantation for diethylnitrosamine-induced tumors in rats.免疫抑制在二乙基亚硝胺诱导的大鼠肿瘤肝移植后复发中的作用。
Transpl Int. 1994;7 Suppl 1:S204-7. doi: 10.1111/j.1432-2277.1994.tb01347.x.
3
Tumor recurrence in liver grafts: two animal models.肝移植中的肿瘤复发：两种动物模型。
Transplant Proc. 1998 Jun;30(4):1052-3. doi: 10.1016/s0041-1345(98)00148-1.
4
5
Role of the thymus in successful transplantation of rat hepatoma cells.胸腺在大鼠肝癌细胞成功移植中的作用。
Transplant Proc. 1998 Nov;30(7):2933-4. doi: 10.1016/s0041-1345(98)00875-6.
6
Development of a rat model for orthotopic liver transplantation for hepatocellular carcinoma.用于肝细胞癌原位肝移植的大鼠模型的建立
Surgery. 1995 Sep;118(3):539-46. doi: 10.1016/s0039-6060(05)80371-x.
7
Cyclosporine enhances the growth of carcinogen-induced enzyme-altered foci in rat liver.环孢素可促进大鼠肝脏中致癌物诱导的酶改变灶的生长。
Hepatology. 1991 Feb;13(2):304-9.
8
A modified rat model for hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int. 2004 Nov;3(4):585-7.
9
FK 506 inhibits the development of transplant arteriosclerosis.FK506可抑制移植动脉硬化的发展。
Transplant Proc. 1991 Dec;23(6):3272-4.
10
Hepatocellular carcinoma is induced by a subnecrogenic dose of diethylnitrosamine in previously fasted-refed rats.在先前禁食再喂食的大鼠中，亚致死剂量的二乙基亚硝胺可诱发肝细胞癌。
Nutr Cancer. 1998;32(1):49-54. doi: 10.1080/01635589809514716.
引用本文的文献
1
CYP2E1 deficit mediates cholic acid-induced malignant growth in hepatocellular carcinoma cells.CYP2E1 缺乏介导胆酸诱导的肝癌细胞恶性生长。
Mol Med. 2024 Jun 7;30(1):79. doi: 10.1186/s10020-024-00844-5.
2
Reduction of FoxP3 Tregs by an immunosuppressive protocol of rapamycin plus Thymalfasin and Huaier extract predicts positive survival benefits in a rat model of hepatocellular carcinoma.在肝癌大鼠模型中，采用雷帕霉素联合胸腺肽α1及槐耳提取物的免疫抑制方案降低FoxP3调节性T细胞可预测出积极的生存获益。
Ann Transl Med. 2020 Apr;8(7):472. doi: 10.21037/atm.2020.03.129.
3
Poly(lactic--glycolic acid)-loaded nanoparticles of betulinic acid for improved treatment of hepatic cancer: characterization, in vitro and in vivo evaluations.桦木酸聚乳酸-聚乙醇酸载药纳米粒用于改善肝癌治疗的研究：表征、体外和体内评价。
Int J Nanomedicine. 2018 Feb 16;13:975-990. doi: 10.2147/IJN.S157391. eCollection 2018.
4
5H-benzo[h]thiazolo[2,3-b]quinazolines ameliorate NDEA-induced hepatocellular carcinogenesis in rats through IL-6 downregulation along with oxidative and metabolic stress reduction.5H-苯并[h]噻唑并[2,3-b]喹唑啉通过下调白细胞介素-6以及减轻氧化和代谢应激来改善NDEA诱导的大鼠肝细胞癌发生。
Drug Des Devel Ther. 2017 Oct 13;11:2981-2995. doi: 10.2147/DDDT.S143075. eCollection 2017.
本文引用的文献
1
Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity.人淋巴细胞对肿瘤靶细胞的自发细胞毒性。IX. 自然杀伤细胞活性的定量分析。
J Clin Immunol. 1981 Jan;1(1):51-63. doi: 10.1007/BF00915477.
2
Supernatant derived from a human hepatocellular carcinoma cell line (PLC/PRF/5) depresses natural killer (NK) cell activity.源自人肝癌细胞系（PLC/PRF/5）的上清液会抑制自然杀伤（NK）细胞的活性。
Cancer Immunol Immunother. 1983;15(3):183-7. doi: 10.1007/BF00199162.
3
The natural history of hepatocellular carcinoma. A study of 100 untreated cases.
Cancer. 1984 Oct 1;54(7):1461-5. doi: 10.1002/1097-0142(19841001)54:7<1461::aid-cncr2820540740>3.0.co;2-7.
4
Cyclosporin prevents diabetes in BB Wistar rats.
Lancet. 1983 Jan 1;1(8314-5):10-2. doi: 10.1016/s0140-6736(83)91558-1.
5
Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy.人类免疫监视的医源性改变及其对恶性肿瘤的影响。
Transplant Rev. 1971;7:112-45. doi: 10.1111/j.1600-065x.1971.tb00465.x.
6
Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors.浸润人类肺部肿瘤的淋巴细胞中自然杀伤细胞细胞毒性活性的降低。
Cancer Res. 1985 Jan;45(1):57-60.
7
Liver resections in cirrhotic patients: a Western experience.
World J Surg. 1986 Apr;10(2):311-7. doi: 10.1007/BF01658152.
8
Role of liver transplantation in cancer therapy.肝移植在癌症治疗中的作用。
Ann Surg. 1985 Oct;202(4):401-7. doi: 10.1097/00000658-198510000-00001.
9
10
Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry.欧洲的肝脏移植。欧洲肝脏移植登记处的首次报告。
Lancet. 1987 Sep 19;2(8560):674-6. doi: 10.1016/s0140-6736(87)92453-6.
Zotero 插件